Noel Ashcraft, DO
Interventional Pain Medicine · Winchester, VANPI 1902099864
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in VA, where the typical reported total is $4,360.
Across 14 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$68
- Boston Scientific$65
- Biodelivery Sciences International, Inc.$38
- SPR Therapeutics, Inc$34
- Merz Pharmaceuticals, LLC$24
- Pacira Pharmaceuticals Incorporated$23
- plus $51 from 3 others
What the payments were for
- Food & beverage$303100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 4 | $68 |
| Boston Scientific | 2 | $65 |
| Biodelivery Sciences International, Inc. | 2 | $38 |
| SPR Therapeutics, Inc | 1 | $34 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Curonix LLC | 1 | $16 |
| Nevro Corp. | 1 | $14 |
How this compares
$303 in reported general payments places this provider in the 5th percentile of 52 interventional pain medicine providers in Virginia.
See all interventional pain medicine providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 234 | $1,984 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $836 |
| Oxycodone Hcl | 35 | $416 |
| Pregabalin | 37 | $401 |
| Tramadol Hcl | 46 | $257 |
| Duloxetine Hcl | 17 | $252 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $161 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Winchester
- Alok GopalWinchester$16K
- Jacob LeeWinchester$14K
- Michael PossWinchester$6K
- Ketan PatelHaymarket$133K
- Che TorryNewport News$48K
- Niteesh BhararaReston$25K
- Sassan HassassianManassas$24K
- Raj SurejaNewport News$23K
- Benjamin SeemanRichmond$21K
- Yaoming GuRichmond$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.